Table 1.

Summary of patient cohorts and performance metrics

	Non-cancer		GBM		Metastasis		Lymphoma		Medulloblastoma
	Specificity (%)	n	Sensitivity (%)	n	Sensitivity (%)	n	Sensitivity (%)	n	Sensitivity (%)	n
Training	100	34	65	31	92	13	29	7	N/A	0
Validation	94	62	74	31	73	52	41	27	78	23